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deformed OARs of the daily CT were smaller than 3 mm for 
99.9% of the surface. The selected registrations were used to 
warp each daily dose distribution to the planning CT. The 
accumulated doses were calculated 1000 times per patient by 
randomly selecting for each fraction one of the warped dose 
distributions. Three types of uncertainties were analyzed for 
the selected registrations: the spatial uncertainties — the 
deviations of the transformed voxels to their average 
positions; the fractional dose uncertainties — the variation of 
the warped voxel doses for each fraction; and the cumulative 
dose uncertainties — the variation of the maximum 
cumulative doses. 
Results: The number of the registrations that fulfilled the 
selection criteria varied largely with the patients and 
fractions, ranging from 5 to 109, emphasizing the need for 
individualized parameter settings for non-rigid registration. 
Over all patients, the average ± 1 SD of the 99th percentiles 
of the spatial uncertainties was 5.2 ± 3.0 mm and was larger 
than 10 mm for three daily CT scans. The average variation in 
fractional dose (1 SD) over all voxels varied between 0.1 Gy 
and 1.1 Gy for the esophagus, 0.1 Gy and 0.6 Gy for the 
stomach and 0.01 Gy and 0.6 Gy for the duodenum. This 
translated into an uncertainty (1 SD) of the cumulative 
maximum doses of 0.04 – 0.6 Gy for the esophagus, 0.03 – 0.4 
Gy for the stomach and 0.01 – 0.2 Gy for the duodenum. For 
one patient the cumulative maximum dose exceeded the 
clinical constraint (the planned dose did not) (Fig 1). 
 
 
Conclusions: Even though all registrations led to visually 
acceptable results, the spatial and dose variation were 
considerable, which confirms the relevance of dealing with 
dose uncertainty caused by non-rigid registration. The results 
further emphasize the need of individualized parameter 
settings for non-rigid registration. This study is an important 
step to introduce non-rigid registration in a clinical setting, 
for instance for adaptive radiotherapy.  
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Purpose/Objective: Radiation therapy for lung cancer 
patients is subject to several geometrical uncertainties due 
to baseline shifts, differential motion and anatomical 
changes over the course of treatment. Adaptive radiotherapy 
(ART) aims to mitigate these uncertainties by adjusting the 
treatment plan. Deformable image registration (DIR) has the 
potential to generate an updated CT image based on the 
daily CBCTs in order to account for systematic deformations 
in adaptive replanning, provided that the accuracy of the DIR 
technique is validated. The aim of this study is to validate an 
in-house developed B-Spline-based DIR approach for CBCT to 
CT registration in lung cancer patients.  
Materials and Methods: Three validation methods have been 
applied to verify the performance of the DIR technique. First, 
the consistency of the DIR was assessed using a full circle 
method. 10 patients with repeated CT (rCT) and CBCT scans 
were used and combinations of pCT, rCT and CBCTs were 
selected to form circles consisting of 3 scans each (24 circles 
in total). Each scan was deformably registered to the next, 
which over the full circle ideally results in a zero deformation 
vector field (DVF). The voxel-wise residual displacements 
(RD) were summarized by mean and SD calculated in LR, CC 
and AP directions, as well as for the vector length. The 
second method involves 1) deforming the pCT to the rCT 
using a non-spline-based approach, developed by RaySearch 
Laboratories, to generate a modified CT (mCT), 2) simulating 
a CB scan based on the mCT (sCB) by forward projection, 
adding noise and scatter and reconstruction, 3) deforming 
the sCB back to the pCT using the B-Spline method, and 
calculating the difference between pCT-to-rCT and sCB-to-
pCT DVFs. This validation approach, in which the underlying 
DVF is known and thus is called the gold standard test, was 
performed on 16 patients. For the last validation step we 
used 12 patients in which gold fiducial markers had been 
implanted in mediastinal lymph nodes. The distance between 
the markers on the pCT and a CBCT was measured before and 
after DIR. 
Results: The mean RD derived from the three validation 
methods are presented in Table 1. The largest RDs in all 
approaches appear in patients with large deformations, 
particularly in case of atelectasis. The accuracy derived from 
method 1&3 revealed an average RD of less than 2 mm.  
 
 
Conclusions: Acceptable accuracy of about 1.5±1mm was 
found for method 1&3. These RD are small relative to the 
underlying day to day geometric uncertainties. The RDs from 
the gold standard approach are higher, which might be 
associated with the finite accuracy of the gold standard. In 
spite of the relatively small RDs, caution must be taken in 
the presence of large low-contrast variations of anatomy in 
the course of treatment. A dosimetric evaluation of adaptive 
interventions using the DIR is required to ascertain the 
acceptability of the RDs. 
 
 
 
 
 
